Literature DB >> 20430484

Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis.

Francisco Hernández-Luis1, Alicia Hernández-Campos, Rafael Castillo, Gabriel Navarrete-Vázquez, Olivia Soria-Arteche, Manuel Hernández-Hernández, Lilián Yépez-Mulia.   

Abstract

A series of 2-(trifluoromethyl)-1H-benzimidazole derivatives (1a-1i) were synthesized via Phillips cyclocondensation of a substituted 1,2-phenylenediamine and trifluoroacetic acid. The synthesized compounds were evaluated in vitro against various protozoan parasites: Giardia intestinalis, Entamoeba histolytica, Trichomonas vaginalis and Leishmania mexicana, and they showed nanomolar activities against the first three protozoa tested. The compounds were also tested in vitro and in vivo against the nematode Trichinella spiralis. Compounds 1b, 1c and 1e had the most desirable in vitro antiparasitic profile against all parasites studied. In the in vivo model against T. spiralis, compounds 1b and 1e showed good activity against the adult phase at 75 mg/Kg. However, against the muscle larvae stage, only compound 1f exhibited in vivo antiparasitic efficacy. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430484     DOI: 10.1016/j.ejmech.2010.03.050

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  Novel and promising compounds to treat Cryptosporidium parvum infections.

Authors:  Zofi Graczyk; Lidia Chomicz; Mariola Kozłowska; Zygmunt Kazimierczuk; Thaddeus K Graczyk
Journal:  Parasitol Res       Date:  2011-02-23       Impact factor: 2.289

2.  RCB20, an experimental benzimidazole derivative, affects tubulin expression and induces gross anatomical changes in Taenia crassiceps cysticerci.

Authors:  Adrián Márquez-Navarro; América Pérez-Reyes; Armando Zepeda-Rodríguez; Olivia Reynoso-Ducoing; Alicia Hernández-Campos; Francisco Hernández-Luis; Rafael Castillo; Lilian Yépez-Mulia; Javier R Ambrosio
Journal:  Parasitol Res       Date:  2013-03-17       Impact factor: 2.289

3.  Systematic search for benzimidazole compounds and derivatives with antileishmanial effects.

Authors:  Juan Carlos Sánchez-Salgado; Pablo Bilbao-Ramos; María Auxiliadora Dea-Ayuela; Francisco Hernández-Luis; Francisco Bolás-Fernández; José L Medina-Franco; Yareli Rojas-Aguirre
Journal:  Mol Divers       Date:  2018-05-10       Impact factor: 2.943

Review 4.  Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review.

Authors:  Sumit Tahlan; Sanjiv Kumar; Balasubramanian Narasimhan
Journal:  BMC Chem       Date:  2019-08-06

5.  Benzimidazole derivatives endowed with potent antileishmanial activity.

Authors:  Michele Tonelli; Elena Gabriele; Francesca Piazza; Nicoletta Basilico; Silvia Parapini; Bruno Tasso; Roberta Loddo; Fabio Sparatore; Anna Sparatore
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

6.  EgGLUT1 Is Crucial for the Viability of Echinococcus granulosus sensu stricto Metacestode: A New Therapeutic Target?

Authors:  Kuerbannisha Amahong; Mingzhi Yan; Jintian Li; Ning Yang; Hui Liu; Xiaojuan Bi; Dominique A Vuitton; Renyong Lin; Guodong Lü
Journal:  Front Cell Infect Microbiol       Date:  2021-11-11       Impact factor: 5.293

7.  On the validity versus utility of activity landscapes: are all activity cliffs statistically significant?

Authors:  Rajarshi Guha; José L Medina-Franco
Journal:  J Cheminform       Date:  2014-04-02       Impact factor: 5.514

8.  Design and Synthesis of Benzimidazole-Chalcone Derivatives as Potential Anticancer Agents.

Authors:  Cheng-Ying Hsieh; Pi-Wen Ko; Yu-Jui Chang; Mohit Kapoor; Yu-Chuan Liang; Hui-Hsien Lin; Jia-Cherng Horng; Ming-Hua Hsu
Journal:  Molecules       Date:  2019-09-06       Impact factor: 4.411

9.  Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma.

Authors:  Fat-Moon Suk; Chao-Lien Liu; Ming-Hua Hsu; Yu-Ting Chuang; Jack P Wang; Yi-Jen Liao
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.